1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Respiratory Distress Syndrome in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (12.50) | 18.7374 |
1990's | 26 (54.17) | 18.2507 |
2000's | 12 (25.00) | 29.6817 |
2010's | 4 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, R; Tong, Z; Wang, H; Wang, Y; Yang, H; Zhang, C | 1 |
Nagase, T | 1 |
Balan, KK; Chilvers, ER; Johnston, A; Mackenzie, IM; Peters, AM; Singh, NR; Solanki, C; Summers, C; White, JF | 1 |
Abdulnour, RE; Colas, RA; Colby, JK; Dalli, J; Krishnamoorthy, N; Levy, BD; Petasis, NA; Serhan, CN; Tan, SH; Timmons, JY | 1 |
Abraham, E; Balk, R; Coyne, E; Levy, H; Lowry, S; Metzler, M; Opal, S; Pribble, J; Schuster, DP; Slotman, G; Souza, S | 1 |
Rabinovici, R | 1 |
Jackson, SK; Jones, KP; Morris, RH; Tonks, A; Tonks, AJ | 1 |
Galani, V; Lekka, ME; Liokatis, S; Nakos, G; Nathanail, C | 1 |
Barnes, PJ | 1 |
Galiatsou, E; Karagiorga, G; Lekka, ME; Nakos, G | 1 |
He, JL; Lu, J; Xu, GL; Yu, SQ; Zhang, LL; Zhou, M | 1 |
Gutbier, B; Ishii, S; Mayer, K; Mitchell, TJ; Owen, JS; Rosseau, S; Schmeck, B; Schütte, H; Suttorp, N; Thomas, MJ; Witzenrath, M | 1 |
Andreadou, I; Arkadopoulos, N; Avgerinos, E; Costopanagiotou, C; Diamantopoulou, K; Kostopanagiotou, G; Lekka, M; Nakos, G; Smyrniotis, V | 1 |
Chen, H; Wang, H; Wang, YL; Xia, SH; Xu, W | 1 |
Hechtman, HB; Shepro, D; Valeri, CR | 1 |
Bond, MG; Lewis, JC; McCall, CE; O'Flaherty, JT; Wykle, RL | 1 |
Kirkpatrick, CJ; Klinge, U; Klosterhalfen, B; Mittermayer, C; Schumpelick, V; Töns, C | 1 |
Cho, PW; Gillinov, AM; Herskowitz, A; Kumar, P; Lee, PC; Poston, RS; Redmond, JM; Uthoff, K; Winkelstein, JA; Zehr, KJ | 1 |
Feuerstein, G; Neville, LF; Rabinovici, R | 1 |
Bernard, GR; Christman, BW | 1 |
Mariscalco, MM | 1 |
Kayahara, H; Kondo, Y; Matsumoto, K; Matsuzaki, M; Takagi, K; Taki, F; Taniguchi, H | 1 |
Bugelski, PJ; Esser, KM; Feuerstein, G; Hillegass, LM; Rabinovici, R; Vernick, J | 1 |
Goldsmith, JA; Kavanagh, BP; Pearl, RG | 1 |
Abdullah, F; Feuerstein, GZ; Neville, LF; Ovadia, P; Rabinovici, R; Whiteford, M | 1 |
Hellewell, PG; Jeffery, PK; Miotla, JM | 1 |
Kitsiouli, EI; Lekka, ME; Nakos, G; Tsangaris, I | 1 |
McIntyre, TM; Prescott, SM; Zimmerman, G | 1 |
Ishii, S; Izumi, T; Kume, K; Nagase, T; Ouchi, Y; Shimizu, T; Uozumi, N | 1 |
Closa, D; Folch, E; Gelpí, E; Panés, J; Piqué, JM; Prats, N; Roselló-Catafau, J; Salas, A | 1 |
Adams, CA; Adams, JM; Deitch, EA; Hauser, CJ; Livingston, DH; Xu, DZ | 1 |
DiMartino, MJ; Feuerstein, G; Fong, KL; Griswold, DE; Hillegass, LM; Rabinovici, R; Vernick, J; Yeh, CG | 1 |
Barnes, PJ; Crawley, DE; Evans, TW; McCormack, DG | 1 |
Chang, SW | 1 |
Kondoh, Y; Matsumoto, K; Takagi, K; Taki, F; Taniguchi, H | 1 |
Elsasser, S; Perruchoud, AP | 1 |
Boogaerts, M; Verhoef, G | 1 |
Feuerstein, G; Rabinovici, R; Vernick, J; Yue, TL | 1 |
Ishizaka, A | 1 |
Fleisher, LN; Joyce, PB; Olson, NC | 1 |
Basha, MA; Kasahara, K; Kunkel, SL; Lynch, JP; Standiford, TJ; Strieter, RM | 1 |
Blair, IA; Christman, BW; Lefferts, PL; Snapper, JR | 1 |
Anderson, BO; Harken, AH | 1 |
Bentwich, Z; Eliraz, A; Fink, A; Geva, D; Konichezky, S; Zung, A | 1 |
König, W; Pison, U; Schmit-Neuerburg, KP | 1 |
Braquet, P; Hosford, D | 1 |
Henderson, WR | 1 |
Levin, DL; Royall, JA | 1 |
14 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Respiratory Distress Syndrome
Article | Year |
---|---|
Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis.
Topics: Antigens, Human Platelet; Biomarkers; Bronchoalveolar Lavage Fluid; Hepatocyte Growth Factor; Humans; Interleukin-8; Lung; Plasminogen Activator Inhibitor 1; Platelet Activating Factor; Receptor for Advanced Glycation End Products; Respiratory Distress Syndrome | 2019 |
[Respiratory failure].
Topics: Acute Lung Injury; Animals; Cytokines; Humans; Platelet Activating Factor; Respiratory Distress Syndrome; Respiratory Insufficiency | 2013 |
Role of platelet activating factor in pathogenesis of acute respiratory distress syndrome.
Topics: Animals; Humans; Hypertension, Pulmonary; Inflammation Mediators; Neutrophil Activation; Platelet Activating Factor; Pulmonary Edema; Respiratory Distress Syndrome | 2007 |
Role of humoral mediators in adult respiratory distress syndrome.
Topics: Animals; Arachidonic Acids; Chemotaxis, Leukocyte; Chromones; Dogs; Guinea Pigs; Humans; Hypertension, Pulmonary; Inflammation; Ketanserin; Leukocyte Count; Leukocytes; Lung; Piperidines; Platelet Activating Factor; Pulmonary Embolism; Respiratory Distress Syndrome; Serotonin; Serotonin Antagonists; SRS-A; Thromboxane A2 | 1984 |
Antilipid mediator and antioxidant therapy in adult respiratory distress syndrome.
Topics: Acetylcysteine; Adrenal Cortex Hormones; Antioxidants; Clinical Trials as Topic; Disease Models, Animal; Epoprostenol; Humans; Inflammation; Intensive Care Units; Leukotrienes; Lipid Peroxidation; Middle Aged; Platelet Activating Factor; Respiratory Distress Syndrome; Thromboxanes; Treatment Failure | 1993 |
Application of differential display to isolate novel genes in interleukin-2-induced adult respiratory distress syndrome.
Topics: Amino Acid Sequence; Animals; Base Sequence; Cytokines; Gene Expression Regulation; Interleukin-2; Lipopolysaccharides; Lung; Microcirculation; Molecular Sequence Data; Platelet Activating Factor; Pulmonary Circulation; Respiratory Distress Syndrome; RNA, Messenger; Tumor Necrosis Factor-alpha | 1996 |
[Mediators and ARDS].
Topics: Arachidonic Acid; Blood Coagulation Disorders; Bronchoalveolar Lavage Fluid; Complement Activation; Cytokines; Endopeptidases; Free Radicals; Humans; Microbial Collagenase; Neutrophils; Platelet Activating Factor; Respiratory Distress Syndrome | 1991 |
PAF and TNF alpha interactions in the pathophysiology of septic shock.
Topics: Animals; Drug Interactions; Endotoxins; Erythrocytes; Humans; Macrophages; Models, Biological; Platelet Activating Factor; Respiratory Distress Syndrome; Shock, Septic; Tumor Necrosis Factor-alpha | 1991 |
[Adult respiratory distress syndrome: a review of cellular mechanisms].
Topics: Animals; Cell Adhesion; Cytokines; Endothelium, Vascular; Humans; Leukocytes; Lung; Phagocytes; Platelet Activating Factor; Proteins; Respiratory Distress Syndrome | 1991 |
Host responses in mediating sepsis and adult respiratory distress syndrome.
Topics: Arachidonic Acid; Arachidonic Acids; Blood Coagulation; Complement System Proteins; Cross Infection; Cytokines; Endopeptidases; Humans; Intensive Care Units; Lipopolysaccharides; Liver; Multiple Organ Failure; Platelet Activating Factor; Pneumonia; Respiratory Distress Syndrome | 1990 |
Multiple organ failure: inflammatory priming and activation sequences promote autologous tissue injury.
Topics: Animals; Endotoxins; Humans; Inflammation; Lung; Multiple Organ Failure; Neutrophils; Peroxidase; Platelet Activating Factor; Respiratory Distress Syndrome | 1990 |
The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS).
Topics: Animals; Brain; Burns; Digestive System; Endotoxins; Humans; Kidney; Lung; Platelet Activating Factor; Respiratory Distress Syndrome; Sepsis; Shock, Septic; Shock, Traumatic | 1989 |
Lipid-derived and other chemical mediators of inflammation in the lung.
Topics: Anaphylatoxins; Arachidonic Acid; Arachidonic Acids; Asthma; Eicosanoic Acids; Fatty Acids; Humans; Leukocytes; Leukotriene B4; Lung; Macrophage Activation; Mucus; Platelet Activating Factor; Pneumonia; Prostaglandin-Endoperoxide Synthases; Respiratory Distress Syndrome; SRS-A | 1987 |
Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury.
Topics: Biomechanical Phenomena; Blood Platelets; Fibrin; Fibrin Fibrinogen Degradation Products; Humans; Infant; Infant, Newborn; Oxygen; Platelet Activating Factor; Pulmonary Surfactants; Respiratory Distress Syndrome | 1988 |
2 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Respiratory Distress Syndrome
Article | Year |
---|---|
Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Logistic Models; Male; Middle Aged; Phospholipases A; Platelet Activating Factor; Prevalence; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Respiratory Distress Syndrome; Sepsis; Survival Analysis; United States | 2003 |
The impact of intravenous fat emulsion administration in acute lung injury.
Topics: Adolescent; Adult; Aged; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Case-Control Studies; Drug Monitoring; Fat Emulsions, Intravenous; Female; Humans; Inflammation; Lung Compliance; Male; Middle Aged; Neutrophils; Phospholipids; Platelet Activating Factor; Proteins; Pulmonary Circulation; Pulmonary Gas Exchange; Respiration, Artificial; Respiratory Distress Syndrome; Survival Analysis; Treatment Outcome; Vascular Resistance | 2004 |
32 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Respiratory Distress Syndrome
Article | Year |
---|---|
Pulmonary retention of primed neutrophils: a novel protective host response, which is impaired in the acute respiratory distress syndrome.
Topics: Blood Flow Velocity; Cell Movement; Erythrocytes; Female; Flow Cytometry; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indium Radioisotopes; Male; Middle Aged; Neutrophils; Platelet Activating Factor; Radionuclide Imaging; Respiratory Distress Syndrome; Spirometry; Technetium; Time Factors | 2014 |
Maresin 1 biosynthesis during platelet-neutrophil interactions is organ-protective.
Topics: Animals; Arachidonate 12-Lipoxygenase; Blood Platelets; Bronchoalveolar Lavage Fluid; Cell Hypoxia; Chemotaxis, Leukocyte; Disease Models, Animal; Docosahexaenoic Acids; Heterografts; Humans; Hydrochloric Acid; Inflammation; Lung; Male; Metabolomics; Mice; Mice, Inbred BALB C; Molecular Structure; Neutrophils; Platelet Activating Factor; Platelet Transfusion; Recombinant Proteins; Respiratory Distress Syndrome; Thrombin | 2014 |
Platelet activating factor inhibition in sepsis: the end?
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Endpoint Determination; Humans; Phospholipases A; Platelet Activating Factor; Research Design; Respiratory Distress Syndrome; Sepsis | 2003 |
Regulation of platelet-activating factor synthesis in human monocytes by dipalmitoyl phosphatidylcholine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Acetyltransferases; Acyltransferases; Cell Line; Humans; Lipopolysaccharides; Membrane Fluidity; Monocytes; Platelet Activating Factor; Pulmonary Surfactants; Respiratory Distress Syndrome | 2003 |
Ceramide lances the lungs.
Topics: Animals; Ceramides; Humans; Inflammation; Lung; Lysophospholipids; Mice; Platelet Activating Factor; Respiratory Distress Syndrome; Sphingomyelin Phosphodiesterase; Sphingosine; Tumor Necrosis Factor-alpha | 2004 |
Biochemical parameters of bronchoalveolar lavage fluid in fat embolism.
Topics: Adolescent; Adult; Biomarkers; Bronchoalveolar Lavage Fluid; Case-Control Studies; Causality; Diagnosis, Differential; Embolism, Fat; Female; Humans; Male; Middle Aged; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Prospective Studies; Respiratory Distress Syndrome; Wounds and Injuries | 2006 |
[Protective effect of rupatadine against oleic acid-induced acute lung injury in rabbits].
Topics: Animals; Blood Gas Analysis; Bronchoalveolar Lavage Fluid; Cyproheptadine; Enzyme-Linked Immunosorbent Assay; Intercellular Adhesion Molecule-1; Interleukin-8; Lung; Male; Oleic Acid; Platelet Activating Factor; Protective Agents; Rabbits; Random Allocation; Respiratory Distress Syndrome | 2007 |
Role of platelet-activating factor in pneumolysin-induced acute lung injury.
Topics: Animals; Bacterial Proteins; Disease Models, Animal; Female; Humans; Hypertension, Pulmonary; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Pneumonia, Pneumococcal; Protein Serine-Threonine Kinases; Respiratory Distress Syndrome; rho-Associated Kinases; Signal Transduction; Streptolysins; Thromboxane A2 | 2007 |
Acute lung injury in a rat model of intestinal ischemia-reperfusion: the potential time depended role of phospholipases A(2).
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Intestines; Lung; Male; Malondialdehyde; Phospholipases A2; Platelet Activating Factor; Pulmonary Gas Exchange; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Respiratory Distress Syndrome; Time Factors | 2008 |
Platelet-activating factor effects on pulmonary ultrastructure in rabbits.
Topics: Animals; Capillaries; Cell Membrane; Cytoplasm; Dose-Response Relationship, Drug; Endothelium; Lung; Microscopy, Electron; Platelet Activating Factor; Rabbits; Respiratory Distress Syndrome | 1983 |
[Septic shock and multiple organ failure in surgical intensive care. An animal experiment model on the analysis of pulmonary and intestinal dysfunction].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Critical Care; Epoprostenol; Escherichia coli Infections; Hemodynamics; Interleukin-6; Intestinal Mucosa; Intestines; Ion Channels; Ischemia; Lung; Microscopy, Electron; Multiple Organ Failure; Platelet Activating Factor; Postoperative Complications; Potassium; Pulmonary Gas Exchange; Respiratory Distress Syndrome; Shock, Septic; Swine; Thromboxane A2; Tumor Necrosis Factor-alpha | 1993 |
Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass.
Topics: Adenosine Diphosphate; Animals; Blood Cell Count; Cardiopulmonary Bypass; CD18 Antigens; Lung; Lung Compliance; Platelet Activating Factor; Platelet Aggregation; Pulmonary Circulation; Quinolinium Compounds; Respiratory Distress Syndrome; Swine; Vascular Resistance | 1995 |
Cytokine gene and peptide regulation in lung microvascular injury: new insights on the development of adult respiratory distress syndrome.
Topics: Animals; Antibodies, Monoclonal; Disease Models, Animal; Drug Synergism; Lipopolysaccharides; Lung; Platelet Activating Factor; Rats; Respiratory Distress Syndrome; RNA, Messenger; Tumor Necrosis Factor-alpha | 1994 |
Leukocytes and the inflammatory response.
Topics: Adhesiveness; Age Factors; Animals; Antibodies, Monoclonal; Antigens, CD; CD11 Antigens; CD18 Antigens; Cell Adhesion Molecules; Cell Movement; Disease Models, Animal; Endothelium; Humans; Infant, Newborn; Inflammation; Interleukin-8; Multiple Organ Failure; Neutrophils; Platelet Activating Factor; Receptors, Leukocyte-Adhesion; Reperfusion Injury; Respiratory Distress Syndrome | 1993 |
[Platelet activating factor and tumor necrosis factor-alpha in bronchoalveolar lavage fluid of patients with ARDS].
Topics: Adolescent; Adult; Aged; Bronchoalveolar Lavage Fluid; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha | 1993 |
ARDS-like lung injury produced by endotoxin in platelet-activating factor-primed rats.
Topics: Animals; Disease Models, Animal; Endotoxins; Hemodynamics; Lipopolysaccharides; Lung; Lung Injury; Male; Microscopy, Electron; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Respiratory Distress Syndrome; Thromboxane B2; Tumor Necrosis Factor-alpha | 1993 |
Plasma potentiates the priming effects of endotoxin on platelet activating factor-induced pulmonary hypertension in the rabbit lung.
Topics: Acute-Phase Proteins; Animals; Blood Pressure; Blood Proteins; Carrier Proteins; Disease Models, Animal; Endotoxins; Escherichia coli; Hypertension, Pulmonary; Lipopolysaccharide Receptors; Lipopolysaccharides; Male; Membrane Glycoproteins; Plasma; Platelet Activating Factor; Pulmonary Artery; Rabbits; Respiratory Distress Syndrome; Serum Albumin | 1996 |
Platelet-activating factor plays a pivotal role in the induction of experimental lung injury.
Topics: Animals; Capillary Permeability; Dihydropyridines; Disease Models, Animal; Elapid Venoms; Extravascular Lung Water; Female; Humans; Imidazoles; Lipopolysaccharides; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome; Serum Albumin; Skin; Zymosan | 1998 |
Bronchoalveolar lavage fluid characteristics of early intermediate and late phases of ARDS. Alterations in leukocytes, proteins, PAF and surfactant components.
Topics: Adolescent; Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; Case-Control Studies; Disease Progression; Female; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Platelet Activating Factor; Prognosis; Prospective Studies; Proteins; Pulmonary Surfactants; Reproducibility of Results; Respiratory Distress Syndrome; Time Factors | 1998 |
Two of the usual suspects, platelet-activating factor and its receptor, implicated in acute lung injury.
Topics: Animals; Mice; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome | 1999 |
Platelet-activating factor mediates acid-induced lung injury in genetically engineered mice.
Topics: Animals; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Phospholipases A; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome | 1999 |
H(2)O(2) and PARS mediate lung P-selectin upregulation in acute pancreatitis.
Topics: Acute Disease; Amylases; Animals; Benzamides; Catalase; Endothelium, Vascular; Enzyme Inhibitors; Free Radical Scavengers; Gene Expression Regulation; Hydrogen Peroxide; Lipase; Lung; Male; P-Selectin; Pancreatitis; Peroxidase; Platelet Activating Factor; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Respiratory Distress Syndrome; Superoxide Dismutase; Taurocholic Acid; Xanthine Oxidase | 2000 |
Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock.
Topics: Analysis of Variance; Animals; Chemokine CXCL2; Chemokines; Lymph; Male; Neutrophils; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Respiratory Burst; Respiratory Distress Syndrome; Shock, Hemorrhagic | 2001 |
Role of complement in endotoxin/platelet-activating factor-induced lung injury.
Topics: Animals; Complement C3; Complement Membrane Attack Complex; Complement System Proteins; Elapid Venoms; Endotoxins; Leukocyte Count; Lipopolysaccharides; Lung; Male; Peroxidase; Platelet Activating Factor; Rats; Rats, Inbred Strains; Receptors, Complement; Receptors, Complement 3b; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha | 1992 |
Bleomycin-induced lung injury in rats selectively abolishes hypoxic pulmonary vasoconstriction: evidence against a role for platelet-activating factor.
Topics: Acetylcholine; Angiotensin II; Animals; Bleomycin; Blood Pressure; Constriction, Pathologic; Hypoxia; In Vitro Techniques; Male; Platelet Activating Factor; Pulmonary Artery; Rats; Rats, Inbred Strains; Respiratory Distress Syndrome; Vasodilation | 1992 |
Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils.
Topics: Animals; Endotoxins; Humans; Lung; Neutrophils; Platelet Activating Factor; Rats; Respiratory Distress Syndrome; Shock, Septic; Tumor Necrosis Factor-alpha | 1992 |
Platelet-activating factor in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome.
Topics: Adolescent; Adult; Aged; Albumins; Bronchoalveolar Lavage Fluid; Cell Count; Female; Humans; Male; Middle Aged; Platelet Activating Factor; Radioimmunoassay; Recombinant Proteins; Respiratory Distress Syndrome; Sensitivity and Specificity; Tumor Necrosis Factor-alpha | 1992 |
Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome.
Topics: Antigens, Differentiation; CD11 Antigens; CD18 Antigens; Cell Adhesion; Cytarabine; Dose-Response Relationship, Drug; Endothelium; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lung; Male; Middle Aged; Neutrophils; Platelet Activating Factor; Receptors, Leukocyte-Adhesion; Respiratory Distress Syndrome; Superoxides; Tumor Necrosis Factor-alpha | 1991 |
Mono-hydroxyeicosatetraenoic acids during porcine endotoxemia. Effect of a platelet-activating factor receptor antagonist.
Topics: Animals; Blood Platelets; Calcimycin; Chromatography, High Pressure Liquid; Disease Models, Animal; Endotoxins; Escherichia coli; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Quinolines; Respiratory Distress Syndrome; Swine | 1990 |
Effect of platelet-activating factor receptor antagonism on endotoxin-induced lung dysfunction in awake sheep.
Topics: Animals; Azepines; Consciousness; Cyclooxygenase Inhibitors; Endotoxins; Escherichia coli; Platelet Activating Factor; Platelet Membrane Glycoproteins; Premedication; Quinolinium Compounds; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Distress Syndrome; Sheep; Thromboxane-A Synthase; Triazoles | 1990 |
Adult respiratory distress syndrome: roles of leukotriene C4 and platelet activating factor.
Topics: Adult; Chromones; Diterpenes; Ginkgolides; Humans; Infections; Lactones; Leukocyte Adherence Inhibition Test; Middle Aged; Platelet Activating Factor; Pulmonary Edema; Respiratory Distress Syndrome; SRS-A | 1990 |
On the pathogenesis of adult respiratory distress syndrome--the role of anaphylatoxins, leukotrienes and platelet activating factor.
Topics: Animals; Capillary Permeability; Complement C5; Complement C5a; Guinea Pigs; Histamine Release; In Vitro Techniques; Leukotriene E4; Mast Cells; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Rats; Rats, Inbred Strains; Respiratory Distress Syndrome; SRS-A | 1987 |